Objective: To assess the association between T cell homeostasis and its failure and 1.) the occurence of AIDS and 2.) the switch from the non-syncytium-inducing (NSI) to the syncytium-inducing (SI) HIV virus phenotype.
Introduction
Immunologic and virologic markers such as CD4 T cell count, HIV RNA concentration, and HIV phenotype [non-syncytium-inducing (NSI) or syncytium-inducing (SI) virus variant] play an important role in assessing the stage of disease in HIV-infected subjects. Although the relations between the various markers and the natural history of HIV infection have been the subject of many studies, biologic mechanisms that may explain these relations are still far from clear. In order to study those mechanisms, various attempts have been made to model associations between marker trajectories and clinical endpoints such as AIDS and death.
Recently, the hypothesis of blind T cell homeostasis has been proposed, based on the observation that in various experimental and clinical conditions a constant level of circulating T cells is maintained without regard to the subset phenotype (e.g. CD4 or CD8 cells) [1] [2] [3] [4] . For example, MHC class I knockout mice, which cannot produce CD4 T cells, generate a CD8 T cell lymphocytosis and maintain normal T cell counts [5] . In HIV-1 infection, progressive loss of CD4 T cells is balanced by an increase in CD8 T cells for many years after HIV-1 seroconversion [4] . Furthermore, it has been found that T cell homeostasis fail in subjects who developed AIDS; this is seen as an abrupt decrease in the CD3 T cell counts which begins about 1.5±2.5 years before the onset of AIDS [3, 6] . The change from steady, or nearly steady, levels of T cells to onset of this decline is the T cell in¯ection point (IP).
Using methods that were developed to identify T cell IP values for individuals [7] , Gange et al. found that more than 75% of participants in the Multicenter AIDS Cohort Study (MACS) who developed AIDS had a T cell IP, with a median time of 1.7 years from the IP to AIDS [7] . While these methods are not appropriate for clinical diagnosis, they allow for investigation of the pathogenesis of the T cell IP. Several recent studies have investigated HIV RNA and cytotoxic lymphocyte patterns [8] , HIV genetic diversity and divergence and predicted chemokine coreceptor usage [9] , and T cell subset composition [10] in relation to T cell IP.
Early in HIV-1 infection, slow-replicating, macrophage-tropic, NSI viruses are the predominant isolates from the peripheral blood. However, in 50% of those with AIDS [11, 12] there is a shift of the virus population towards the more rapidly replicating, T cell-tropic, SI phenotype. The median time interval between the switch from the NSI to the SI viral phenotype and the onset of AIDS has been estimated as 6±18 months [13] and 23 months [14] . The similarity of these intervals to the time between the T cell IP and AIDS suggests that these events may be related. However, no studies have directly investigated whether this is true. The present study was undertaken to investigate this relation in the Amsterdam Cohort Study (ACS), in which HIV-1 phenotype has been assessed on cohort members every 3 months since the beginning of the study in 1984. In the present study, we ®rst evaluated the validity of the blind T cell homeostasis hypothesis in the ACS, determining individual T cell IP and CD3 cell level versus time slopes (CD3 slopes) before and after this point. Subsequently, the association between the calculated IP parameters and the appearance of the SI virus phenotype was studied.
Materials and methods

Study group
Since October, 1984, 1294 homosexual men have been enrolled on an ongoing basis in the ACS according to procedures that have been previously described [15] . Brie¯y, participants have been seen every 3 months, at which time a medical history was taken, a physical examination was performed, and blood was drawn for immunologic and virologic laboratory evaluations. Sera were tested for the presence of HIV-1 antibodies with two commercially available enzyme-linked immunosorbent assays (Abbott Laboratories, North Chicago, Illinois, USA and Vironostika Teknika, Organon, Oss, The Netherlands) and results con®rmed with Western blot. All serologic tests were carried out using fresh sera. T cell subsets were measured by¯ow cytometry as described using fresh cells and directly conjugated monoclonal antibodies [16] .
Participants in the present study were selected from the 679 HIV-1-infected individuals (543 seroprevalents and 136 seroconverters) who had been enrolled in the ACS in the period up to February 1998 according to three criteria: individuals had to have at least six T cell measurements, they had to have at least 3 years of follow-up, and the ®rst two criteria had to be met before 15 June 1996, the date on which highly active antiretroviral therapy (HAART) was introduced in the ACS. No distinction was made between seroprevalent subjects and seroconverters [7] . The median age of the participants was 33.7 years [interquartile range (IQR) 29±58]. Those who met these criteria (n 338) were divided into three groups; (1) those who developed AIDS, according to the 1987 Center for Disease Control and Prevention case de®nition [17] by 15 June 1996 (the AIDS group; n 178); (2) those who developed AIDS between 15 June 1996 and February 1998 (n 13); and (3) those who had not developed AIDS as of February 1998 (the AIDS-free group; n 147). Members of the second group were excluded from analysis in this study. T cell counts from the third group were truncated at 1 January 1995, to assure that T cell counts in this group were not affected by any imminent development of AIDS. Finally, persons who started HAART within an interval of 2 years after the IP or NSI/SI switch were excluded from the analysis.
Analysis of T cell in¯ections and trajectories
The statistical methods used to estimate T cell IP, and the CD3 T cell slopes before and after the IP for a given individual, have been described elsewhere [7] ( Fig. 1 ). Brie¯y, a segmented regression model of the form
å ij was ®t, where y ij represents the log 10 CD3 cell count for the measurement of the ith individual at the time t ij ; IP i is the estimated time of loss of T cell homeostasis for the ith individual, and å ij is a random normal error term. The parameter â i0 represents the log 10 CD3 cell count at the time T cell homeostasis fails, and the parameters â i1 and â i2 represent the slope of the log 10 CD3 cell count before and after the IP, respectively. We evaluated the parameters â i1 (pre-IP slope), â i2 (post-IP slope), and â i1 ± â i2 (difference between the pre-and post-IP slopes) for distinguishing individuals in the AIDS and AIDS-free groups. To determine the slope value that best discriminated these two groups, we calculated the value that maximized the sensitivity and speci®city for the development of AIDS using receiver operator characteristic (ROC) curves [18] . Subjects with post-IP slopes steeper than the cutoff were de®ned as`true in¯ectors' while those with a slope less steep than the cutoff were de®ned as`nonin¯ectors'.
Determination of viral phenotypic switch and relation of the switch to T cell in¯ections
To detect the presence of SI HIV-1 variants, peripheral blood mononuclear cells (PBMC) were cultivated with MT-2 cells, which is a sensitive and speci®c method for detection of SI isolates [16] . Brie¯y, HIV-1 was isolated from 0.5 3 10 6 fresh or 1 3 10 6 cryopreserved PBMC from infected men by cocultivation with 1.0 3 10 6 MT-2 cells (MRC AIDS Reagent Project, Potters Bar Hertfordshire, United Kingdom), as previously described [16] . Cryopreserved cells were used until October 1992, and fresh cells thereafter. Cultures were kept for 3 weeks. Virus replication was detected by observation of syncytium formation and detection of HIV-1 p24 in the culture supernatant. From subjects with at least two viral phenotype measurements, the time of the NSI to SI switch was taken as the midpoint between the time of the last NSI measurement and that of the ®rst SI measurement, with the restriction that the two measurements had to be within 12 months of each other. Persons who started HAART within 2 years after the IP or NSI/SI switch were excluded (n 9). With these restrictions, there were 267 persons with phenotypic measurements. The median number of phenotypic measurements per person was 15 (IQR 7±23), and the median interval between measurements was 3.6 months (IQR 3.0±6.3). The association between the NSI to SI switch and T cell IP was analyzed by non-parametric tests (Mann±Whitney and Wilcoxon signed rank test or sign test, depending on the symmetry of the distribution), logistic regression and least squares linear regression.
Results
T cell homeostasis and its failure in relation to AIDS Figure 2 gives an overview of the number of participants included in this study. A total of 325 subjects met the selection criteria; of these, 178 developed clinically de®ned AIDS by June 1996, and 147 remained AIDS free to February 1998. The median follow-up of the subjects who developed AIDS and those who remained AIDS free was 5.5 years (IQR 4.2±7.3) and 8.0 years (IQR: 5.8±11.5), respectively. The median time to AIDS was 5.6 years (IQR: 4.1±7.8). The time to AIDS slightly exceeded the follow-up time because follow-up was terminated when subjects with suspected AIDS were referred to a hospital, while the diagnosis of AIDS was not formally established until after hospitalization. For this reason, almost all of the T cell counts analyzed were obtained before an AIDS diagnosis. Three subjects were excluded because they started HAART therapy within 2 years after IP. Figure 3 changes in the CD3 T cell counts before and after the IP for those with AIDS (n 176) and the AIDS-free group (n 146). For both groups, the distribution of the pre-IP slopes was essentially centered around zero (À0.02%/year for the AIDS group and À3.5%/year for the AIDS-free group). In contrast, the post-IP slopes differed signi®cantly (P , 0.001) between the two groups: the median post-IP slope was À17.6%/year (IQR À46.0 to À0.09) for the AIDS group and 4.6%/year (IQR À6.1 to 19.0) for the AIDS-free group. These data are in complete agreement with the T cell homeostasis hypothesis, which predicts CD3 cell stability at all time periods in the AIDS-free group and prior to the T cell IP in the AIDS group.
The ROC analysis demonstrated that the post-IP slope was the strongest predictor for AIDS, followed by the difference between the pre-and post-IP slopes (data not shown). The optimal cut-off for distinguishing true in¯ectors from non-in¯ectors based on the post-IP slope was a slope of À8.2%/year. This cutoff, which resulted in sensitivity and speci®city for prediction of AIDS onset of 66%, was used to de®ne the individuals included in the subsequent analyses of the relations between the T cell IP and AIDS, and the T cell IP and the SI switch, as described below. The true in¯ectors included 118 of the 176 who had AIDS (67%) and 32 of the 146 AIDS-free subjects (22%). Among the 118 true in¯ectors who developed AIDS, the median time between the T cell IP and AIDS was 1.58 years (IQR 0.83±2.6). Again, these estimates were not in¯uenced by HAART, because all individuals with an interval of 2 years or less between IP and HAART were excluded.
The median CD3, CD4, and CD8 T cell counts at the visit just prior to the estimated T cell IP were 1490, 420, and 1000 3 10 6 cells/l, respectively; and at the ®rst visit after the T cell IP they were 1110, 330, and 760 3 10 6 cells/l, respectively.
Relation of the viral phenotype switch to the T cell IP and to AIDS NSI/SI phenotype data were available for 267 of the 325 individuals eligible for this study: 133/176 (75.6%) of the AIDS group and 134/146 (91.7%) of the AIDSfree group (Fig. 2) . Three subjects were excluded because they had started HAART therapy within 2 years after CD3 cell IP; an additional six subjects were excluded because they had an interval shorter than 2 years from the SI switch to the start of HAART therapy. Subsequently, the proportion of men who developed AIDS was analyzed as a function of the presence or absence of SI switch and T cell IP, as shown in Table  1 . There were 119 men who had both eligible NSI/SI phenotype assessments and a true T cell IP (i.e., a post-IP T cell decline slope > 8.2%/year). Among these true in¯ectors, the proportion developing AIDS was high, regardless of whether an SI switch was present (80%) or not present (72%). Among non-in¯ectors, the proportion developing AIDS was much lower, although it was somewhat higher in those who had an SI switch (42%) than in those who did not (25%). These results are consistent with the hypothesis that some of the association between the SI switch and the development of AIDS is mediated by the failure of T cell homeostasis. However, since a higher risk of AIDS persisted among the non-in¯ectors with a SI switch than in those without a switch, there appears to be an association of SI with AIDS via a pathway independent of failure in T cell homeostasis.
The distribution of the time intervals between the true IP and the SI switch is shown in Fig. 4 . Among true in¯ectors who developed AIDS (n 49), the SI switch generally preceded the IP (median interval 0.63 years; IQR 1.35±0.01; P , 0.001). However, for true in¯ec-tors without AIDS (n 12), these events occurred more contemporaneously (median interval 0.0 years; IQR À1.3 to 0.8). Overall, there was a very strong linear relation between the time of the SI switch and the time of the true IP, as shown in Fig. 5 . The intercept of the regression line was estimated to be 0.73 years, consistent with the previous analysis.
Finally, the in¯uence of viral phenotype on T cell slopes before and after the IP was assessed. Using only data from the 119 true in¯ectors, the T cell decline post-IP was substantially steeper for men with an SI virus (median slope À40.2%/year; IQR À54.8 to À17.3) than for men with NSI viruses (median slope À25.2%/year; IQR À44.8 to À15.9). This difference was of borderline statistical signi®cance (P 0.07). As expected, there was also no difference regarding the pre-IP slopes (4.7%/year and 6.3%/year for SI and NSI phenotypes, respectively; P 0.16). If the analysis was extended to all 267 subjects (i.e., without regard to whether they were true in¯ectors), there was no difference in the pre-IP slopes for those with and without the SI viral phenotype (medians À0.06%/year and À2.7%/year, respectively; P 0.3); however, subjects who had an SI switch had signi®cantly steeper post-IP T cell declines than those who had an IP without an SI switch (medians À17.3%/year and À1.1%/year, respectively; P , 0.001).
Discussion
This study has provided further support for the blind T cell homeostasis concept, in that a biphasic trajectory Years between appearance of SI phenotype and IP was observed, with a nearly stable number of peripheral CD3 T cells in the ®rst phase followed by a steep decline in CD3 T cells in the second phase. The IP for this change occurred a median of 1.58 years before the onset of AIDS. This is in close accordance with the results found in the MACS, where a median of 1.72 years was found [7] .
In the second part of this study, we examined the association between the appearance of the SI phenotype in peripheral blood and the time and magnitude of the T cell IP. In subjects who developed AIDS, there was a strong temporal association between the T cell IP and the ®rst appearance of the SI virus phenotype. Speci®cally, the SI switch occurred a median of 0.63 years before the T cell IP, which agrees closely with the ®nding by Shankaprappa et al. that X4 viruses were maximally represented a mean of 1.08 years before the T cell IP in eight homosexual men in the MACS who progressed to advanced HIV-1 disease [9] . While NSI/SI phenotype did not affect the pre-IP slopes, post-IP CD3 cell slopes were signi®cantly steeper among SI carriers than NSI carriers.
There are several possible mechanisms by which SI HIV-1 variants may be associated with failure of T cell homeostasis. One of the mechanisms may be an expanded host range for SI variants compared with NSI variants. CCR5, the coreceptor for NSI variants, is expressed primary on memory T cells whereas CXCR4, the SI coreceptor, is expressed on both memory and naive cells. In agreement with this expression pattern, NSI variants were mainly isolated from memory cells whereas SI variants were equally distributed among naive and memory cell populations [19] . Thus SI variants could have a large impact on T cell homeostasis because of both their greater target cell range and their infection and destruction of naõ Ève cells that normally contribute to T cell repopulation. Herbein et al. found that the SI phenotype can be associated with apoptosis of non-infected T cells [21] . Another possible explanation is that in some individuals with rapid progression to AIDS, dual tropic SI variants (i.e., capable of replicating in both T cells and macrophages) occur [22] . It has been postulated that the observed T cell turnover in HIV infection can be viewed as the reverse of the process by which immune reconstitution occurs after stem cell transplantation [4] , and Hellerstein et al. [23] found that T cells from HIVinfected individuals had reduced half-lives compared with those from healthy, HIV-negative individuals. Finally, Glushakova et al. [24] found that speci®c immune responses were enhanced by productive infection of tissue with NSI isolates, but these responses were blocked by SI isolates. In other words, broadening of the HIV target cell population [20] to include the naive T cell population, SI-induced impairment of the immune responses and a reduced T cell half-life may together be the driving forces behind loss of T cell homeostasis and an accelerated progression of infection.
